namzaric

Generic: memantine hydrochloride and donepezil hydrochloride

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name namzaric
Generic Name memantine hydrochloride and donepezil hydrochloride
Labeler allergan, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

donepezil hydrochloride 10 mg/1, memantine hydrochloride 21 mg/1

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 0456-1221
Product ID 0456-1221_e71e99c9-2fad-4215-baad-4d8e63a4500b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA206439
Listing Expiration 2026-12-31
Marketing Start 2016-07-18

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa] n-methyl-d-aspartate receptor antagonist [epc] nmda receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04561221
Hyphenated Format 0456-1221

Supplemental Identifiers

RxCUI
1599803 1599805 1602588 1602594 1805420 1805422 1805425 1805427 1858970 1858971
UPC
0304561221301 0304561214303 0304561207305
UNII
JY0WD0UA60 3O2T2PJ89D

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name namzaric (source: ndc)
Generic Name memantine hydrochloride and donepezil hydrochloride (source: ndc)
Application Number NDA206439 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
  • 21 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (0456-1221-30)
source: ndc

Packages (1)

0456-1221-30 30 CAPSULE in 1 BOTTLE (0456-1221-30)

Ingredients (2)

donepezil hydrochloride (10 mg/1) memantine hydrochloride (21 mg/1)

Linked Drug Pages (1)

Namzaric ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e71e99c9-2fad-4215-baad-4d8e63a4500b", "openfda": {"upc": ["0304561221301", "0304561214303", "0304561207305"], "unii": ["JY0WD0UA60", "3O2T2PJ89D"], "rxcui": ["1599803", "1599805", "1602588", "1602594", "1805420", "1805422", "1805425", "1805427", "1858970", "1858971"], "spl_set_id": ["90fedc32-19e5-480c-afc6-f35a5cf4b9aa"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (0456-1221-30)", "package_ndc": "0456-1221-30", "marketing_start_date": "20160718"}], "brand_name": "Namzaric", "product_id": "0456-1221_e71e99c9-2fad-4215-baad-4d8e63a4500b", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]", "N-methyl-D-aspartate Receptor Antagonist [EPC]", "NMDA Receptor Antagonists [MoA]"], "product_ndc": "0456-1221", "generic_name": "memantine hydrochloride and donepezil hydrochloride", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Namzaric", "active_ingredients": [{"name": "DONEPEZIL HYDROCHLORIDE", "strength": "10 mg/1"}, {"name": "MEMANTINE HYDROCHLORIDE", "strength": "21 mg/1"}], "application_number": "NDA206439", "marketing_category": "NDA", "marketing_start_date": "20160718", "listing_expiration_date": "20261231"}